This project, led by Jun.-Prof. Dr. Anna Stöckl and Prof. Dr. Axel Meyer (University of Konstanz), investigates how moths adapt to artificial light at night. By combining genomics, neuroanatomy and behavioral studies, the team aims to elucidate the mechanisms of sensory plasticity during metamorphosis. Using transcriptomics, epigenetics, and behavioral analysis, the research will investigate how caterpillar light exposure affects adult moths. The results will provide critical insights into animal adaptation to human-induced environmental change and shape future ecological and evolutionary studies.

This project, led by Prof. Dr. Dr. h.c. Ralf Bartenschlager (University of Heidelberg) and Prof. Dr. Tessa Quax (University of Groningen), investigates whether archaic viruses form specialized replication compartments, a strategy that has already been demonstrated in bacterial and eukaryotic viruses. By combining structural biology, cell biology, medicine, and chemistry, the goal is to identify universal mechanisms of viral replication. Using advanced imaging, genetic labeling, and lipid analysis, the viral replication process in archaea will be studied and compared to other life forms. The results will provide new insights into the evolution of viruses and identify potential approaches for antiviral therapies. In addition, young scientists will be trained in interdisciplinary virology to promote virus research in different biological areas.

The aim of the project led by Hector RCD Awardee Agnieszka Nowak-Król (University of Würzburg) and Hector Fellow A. Stephen K. Hashmi (Heidelberg University) is to develop well-defined helically chiral gold(III) complexes, the first examples of helically chiral gold complexes with gold atoms on either an outer or an inner helicene rim. The catalytic potential of these unprecedented complexes and their practical utility will be demonstrated in the enantioselective synthesis of small organic compounds and biologically or pharmaceutically relevant targets, i.e. natural products and pharmaceutically active compounds.